myelodysplastic syndrome
Showing NaN - NaN of 28
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +5 more
-
Anchorage, Alaska
- +506 more
Jan 28, 2023
Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +3 more
Jan 12, 2023
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland
Not yet recruiting
- Allogeneic Stem Cell Transplant Candidate
- +4 more
- Cellular therapy product
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 1, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)
Completed
- Myelodysplastic Syndrome
- +3 more
-
Tampa, Florida
- +5 more
Jan 14, 2022
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United
Completed
- Acute Biphenotypic Leukemia
- +4 more
- Cyclophosphamide
- +7 more
-
Duarte, California
- +7 more
Jun 13, 2021
Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Azacitidine
- +2 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Idarubicin
- +2 more
-
Tampa, Florida
- +1 more
Dec 1, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Cancer Survivor, Depression, Hematopoietic and Lymphoid Cell Tumor Trial in United States (Internet-Based Intervention, Medical
Completed
- Cancer Survivor
- +3 more
- Internet-Based Intervention
- +3 more
-
Tampa, Florida
- +5 more
Jul 29, 2020
Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))
Terminated
- Myelodysplastic Syndrome
- vadastuximab talirine
- +2 more
-
Gilbert, Arizona
- +33 more
Jan 23, 2019
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Canada, United States (Co-ArgI-PEG modified human arginase I)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Co-ArgI-PEG modified human arginase I
-
Ann Arbor, Michigan
- +9 more
Oct 15, 2018